142 related articles for article (PubMed ID: 3455751)
1. Aclacinomycin A and behenoyl arabinofuranosylcytosine combination chemotherapy for previously untreated acute leukemia.
Sampi K; Sakurai M; Kaneko Y; Hattori M
Oncology; 1986; 43(1):18-22. PubMed ID: 3455751
[TBL] [Abstract][Full Text] [Related]
2. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
Sampi K; Honda T; Hayashi Y; Hattori M
Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
[TBL] [Abstract][Full Text] [Related]
3. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
Ishige K; Takagi T; Oguro M
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
[TBL] [Abstract][Full Text] [Related]
4. Nationwide randomized comparative study of daunorubicin and aclarubicin in combination with behenoyl cytosine arabinoside, 6-mercaptopurine, and prednisolone for previously untreated acute myeloid leukemia.
Nagura E; Kimura K; Yamada K; Ohta K; Maekawa T; Takaku F; Uchino H; Masaoka T; Amaki I; Kawashima K
Cancer Chemother Pharmacol; 1994; 34(1):23-9. PubMed ID: 8174198
[TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy with idarubicin plus N4-behenoyl-1-beta-D-arabinofuranosylcytosine in acute myelogenous leukemia: a newly designed induction regimen--a prospective, cooperative multicenter study.
Park HS; Kim DW; Kim CC; Kim HK; Kim JS; Hwang TJ; Kim HJ; Kim HS; Song HS; Park JW; Ahn HS; Chung TJ; Cho KS; Lee KS; Choi YM
Semin Hematol; 1996 Oct; 33(4 Suppl 3):24-9. PubMed ID: 8916313
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center.
Sampi K; Sakurai M; Kaneko Y; Hattori M
Anticancer Res; 1985; 5(3):293-6. PubMed ID: 4015043
[TBL] [Abstract][Full Text] [Related]
7. Aclarubicin plus cytosine arabinoside versus daunorubicin plus cytosine arabinoside in previously untreated patients with acute myeloid leukemia: a Danish national phase III trial. The Danish Society of Hematology Study Group on AML, Denmark.
Hansen OP; Pedersen-Bjergaard J; Ellegaard J; Brincker H; Boesen AM; Christensen BE; Drivsholm A; Hippe E; Jans H; Jensen KB
Leukemia; 1991 Jun; 5(6):510-6. PubMed ID: 2056774
[TBL] [Abstract][Full Text] [Related]
8. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
[No Abstract] [Full Text] [Related]
9. Phase I--II evaluation of a new anthracycline antibiotic, aclacinomycin A, in adults with refractory leukemia.
Warrell RP; Arlin ZA; Kempin SJ; Young CW
Cancer Treat Rep; 1982 Aug; 66(8):1619-23. PubMed ID: 6955022
[TBL] [Abstract][Full Text] [Related]
10. [Mucosal injury of aclacinomycin A in patients with adult acute leukemia--comparison of BH-AC. AMP therapy and BH-AC. DMP therapy].
Takeyama H; Kataoka T; Yano K; Fukutani H; Watanabe E
Rinsho Ketsueki; 1986 Apr; 27(4):508-13. PubMed ID: 3461186
[No Abstract] [Full Text] [Related]
11. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
[TBL] [Abstract][Full Text] [Related]
12. [Adriamycin-aclacinomycin therapy (AA therapy) for acute leukemia unresponsive to BH-AC-DMP therapy].
Kobayashi M; Tahara T
Gan To Kagaku Ryoho; 1983 Jun; 10(6):1473-9. PubMed ID: 6575727
[TBL] [Abstract][Full Text] [Related]
13. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute myelogenous leukemia with concurrent administration of N4-behenoyl-ara-C, aclacinomycin A, 6-mercaptopurine and prednisolone].
Ino T; Saito M; Matsui T; Shimizu S; Shigemura H; Nakamura K; Ono Y; Okamoto M; Takada T; Imura H
Rinsho Ketsueki; 1985 Feb; 26(2):139-46. PubMed ID: 3860668
[No Abstract] [Full Text] [Related]
15. Clinical use of intermediate to high dose of N4-behenoyl-1-beta-D-arabinofuranosylcytosine in children with acute leukemia.
Takashima Y
J Clin Pharmacol; 1988 Apr; 28(4):356-62. PubMed ID: 3164731
[TBL] [Abstract][Full Text] [Related]
16. Phase I-II study of aclarubicin for treatment of acute myeloid leukemia.
Machover D; Gastiaburu J; Delgado M; Goldschmidt E; Hulhoven R; Misset JL; de Vassal F; Tapiero H; Ribaud P; Schwarzenberg L
Cancer Treat Rep; 1984 Jun; 68(6):881-6. PubMed ID: 6587933
[TBL] [Abstract][Full Text] [Related]
17. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
Beck JD
Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
[TBL] [Abstract][Full Text] [Related]
18. [Effect of etoposide added to individualized induction therapy of adult acute myeloid leukemia--the JALSG-AML-92 Study. Japan Adult Leukemia Study Group].
Miyawaki S; Tanimoto M; Kobayashi T; Minami S; Tamura J; Omoto E; Kuriyama K; Hatake K; Saito K; Ohno R
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1160-7. PubMed ID: 10945011
[TBL] [Abstract][Full Text] [Related]
19. Aclacinomycin-A in the induction treatment of childhood AML.
Fink FM; Grümayer ER; Kardos G; Revesz T; Gadner H; Schuler D
Onkologie; 1986 Jun; 9(3):154-5. PubMed ID: 3528963
[TBL] [Abstract][Full Text] [Related]
20. [Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)].
Shimazaki C; Nakajima Y; Ura Y; Hamami T; Haruyama H; Isemura T; Nakagawa M; Ijichi H
Rinsho Ketsueki; 1981 Jul; 22(7):1116-22. PubMed ID: 6948970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
